‘Generation Z’ happy to be diagnosed by chatbots

A survey involving young people from ‘Generation Z’ has revealed they want to see the NHS introduce digital solutions to help manage their care, with nearly two thirds saying they would be comfortable with a chatbot giving them a diagnosis.

The new research from Roche UK showed 82% of those in the 16-24 year old age bracket want to see more use of digital technology on the NHS.

Findings showed nearly two thirds (63%) of young people would be comfortable with a chatbot giving them a diagnosis when they are ill, compared to just over one in three (38%) of those over 55.

Over half (56%) of those surveyed in Generation Z would also rather receive advice from their GP or clinical pharmacists via an app or website than face-to-face (44%).

More than eight in ten (82%) would be comfortable with the NHS genetically profiling tumours to allow more accurate clinical decision making.

Almost three quarters (73%) are happy to test and share their genetic data to identify the risk of developing certain diseases and offering treatment that is personalised to someone’s specific genetic make-up.

Young people are also concerned about the future of health provision, with over a third (34%) of those aged 16-24 thinking the NHS is currently not well prepared to meet the future needs of the nation.

Dr Rav Seeruthun, Medical Director at Roche Products Limited said: “These are exciting times. Public demand for change, combined with breakthroughs in technology has the potential to take us into a new era in healthcare.

“The public are increasingly used to and expect bespoke services which has huge implications for personalised medicine. The challenge has been set, and we, along with government and the industry need to respond.  I’m passionate about making this a reality and Roche plan to be a central part of it.”

Findings were based on a survey of 5,141 people, including 1,056 16-24 year-olds, conducted between 3rd and 14th of August this year.

 

 

 

Don't miss your daily pharmaphorum news.
SUBSCRIBE free here.